Keyphrases
Active Metabolite
20%
Capecitabine
100%
Cutaneous Abnormalities
20%
Cutaneous Adverse Drug Reactions (cADRs)
20%
Dermatological Adverse Effects
20%
Metastatic Breast Cancer
40%
Metastatic Colorectal Cancer (mCRC)
20%
Offending Drugs
20%
Palmar-plantar Erythrodysesthesia
100%
Prodrug
20%
Starting Treatment
20%
Systemic Lupus Erythematosus
100%
Therapy-systemic
20%
Xeloda
20%
Medicine and Dentistry
Active Metabolite
16%
Antiinfective Agent
16%
Capecitabine
100%
Colorectal Carcinoma
16%
Dermatological Agent
16%
Hand Foot Syndrome
100%
Metastatic Breast Cancer
33%
Prodrug
16%
Side Effect
50%
Systemic Lupus Erythematosus
100%
Pharmacology, Toxicology and Pharmaceutical Science
Active Metabolite
16%
Antiinfective Agent
16%
Capecitabine
100%
Dermatological Agent
16%
Hand Foot Syndrome
100%
Metastatic Breast Cancer
33%
Metastatic Colorectal Cancer
16%
Prodrug
16%
Side Effect
50%
Systemic Lupus Erythematosus
100%